1. Home
  2. TAK vs PCAR Comparison

TAK vs PCAR Comparison

Compare TAK & PCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • PCAR
  • Stock Information
  • Founded
  • TAK 1781
  • PCAR 1905
  • Country
  • TAK Japan
  • PCAR United States
  • Employees
  • TAK N/A
  • PCAR N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • PCAR Auto Manufacturing
  • Sector
  • TAK Health Care
  • PCAR Consumer Discretionary
  • Exchange
  • TAK Nasdaq
  • PCAR Nasdaq
  • Market Cap
  • TAK 45.8B
  • PCAR 47.8B
  • IPO Year
  • TAK N/A
  • PCAR N/A
  • Fundamental
  • Price
  • TAK $14.68
  • PCAR $97.21
  • Analyst Decision
  • TAK
  • PCAR Hold
  • Analyst Count
  • TAK 0
  • PCAR 10
  • Target Price
  • TAK N/A
  • PCAR $102.90
  • AVG Volume (30 Days)
  • TAK 2.3M
  • PCAR 2.8M
  • Earning Date
  • TAK 07-30-2025
  • PCAR 07-22-2025
  • Dividend Yield
  • TAK 3.70%
  • PCAR 4.35%
  • EPS Growth
  • TAK N/A
  • PCAR N/A
  • EPS
  • TAK 0.45
  • PCAR 6.59
  • Revenue
  • TAK $30,595,075,281.00
  • PCAR $32,361,200,000.00
  • Revenue This Year
  • TAK $1.01
  • PCAR N/A
  • Revenue Next Year
  • TAK $1.04
  • PCAR $8.59
  • P/E Ratio
  • TAK $65.09
  • PCAR $14.75
  • Revenue Growth
  • TAK 7.45
  • PCAR N/A
  • 52 Week Low
  • TAK $12.80
  • PCAR $84.65
  • 52 Week High
  • TAK $15.53
  • PCAR $118.81
  • Technical
  • Relative Strength Index (RSI)
  • TAK 41.31
  • PCAR 55.86
  • Support Level
  • TAK $14.93
  • PCAR $96.08
  • Resistance Level
  • TAK $15.14
  • PCAR $100.60
  • Average True Range (ATR)
  • TAK 0.15
  • PCAR 2.09
  • MACD
  • TAK -0.06
  • PCAR 0.34
  • Stochastic Oscillator
  • TAK 11.86
  • PCAR 67.87

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About PCAR PACCAR Inc.

Paccar is a leading manufacturer of medium- and heavy-duty trucks under the premium nameplates Kenworth and Peterbilt, which are primarily sold in the Americas and Australia, and DAF, which primarily services Europe and South America. The trucks segment (74% sales) goes to market through a network of 2,200 independent dealers. Paccar maintains an internal finance subsidiary that provides retail and wholesale financing for customers and dealers (6% sales). In recent years, Paccar has aggressively grown its parts business (20% sales), which include engines, axles, and transmissions for its own truck brands as well as independent producers. The company commands approximately 30% of the Class 8 market share in North America and 15% of the heavy-duty market share in Europe.

Share on Social Networks: